Follow
Hiroshi Miyamoto
Hiroshi Miyamoto
University of Rochester Medical Center
Verified email at urmc.rochester.edu
Title
Cited by
Cited by
Year
The International Society of Urological Pathology (ISUP) vancouver classification of renal neoplasia
JR Srigley, B Delahunt, JN Eble, L Egevad, JI Epstein, D Grignon, O Hes, ...
The American journal of surgical pathology 37 (10), 1469-1489, 2013
12212013
The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters
B Delahunt, JC Cheville, G Martignoni, PA Humphrey, C Magi-Galluzzi, ...
The American journal of surgical pathology 37 (10), 1490-1504, 2013
7582013
Promotion of bladder cancer development and progression by androgen receptor signals
H Miyamoto, Z Yang, YT Chen, H Ishiguro, H Uemura, Y Kubota, ...
Journal of the National Cancer Institute 99 (7), 558-568, 2007
4322007
Androgen deprivation therapy for prostate cancer: current status and future prospects
H Miyamoto, EM Messing, C Chang
The Prostate 61 (4), 332-353, 2004
4232004
From estrogen to androgen receptor: a new pathway for sex hormones in prostate
S Yeh, H Miyamoto, H Shima, C Chang
Proceedings of the National Academy of Sciences 95 (10), 5527-5532, 1998
3301998
Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells
H Miyamoto, S Yeh, G Wilding, C Chang
Proceedings of the National Academy of Sciences 95 (13), 7379-7384, 1998
2751998
Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder
H Miyamoto, JL Yao, A Chaux, Y Zheng, I Hsu, K Izumi, C Chang, ...
BJU international 109 (11), 1716-1726, 2012
2232012
Non‐invasive papillary urothelial neoplasms: the 2004 WHO/ISUP classification system
H Miyamoto, JS Miller, DA Fajardo, TK Lee, GJ Netto, JI Epstein
Pathology international 60 (1), 1-8, 2010
2122010
Non‐invasive papillary urothelial neoplasms: the 2004 WHO/ISUP classification system
H Miyamoto, JS Miller, DA Fajardo, TK Lee, GJ Netto, JI Epstein
Pathology international 60 (1), 1-8, 2010
2122010
Renal tumors: diagnostic and prognostic biomarkers
PH Tan, L Cheng, N Rioux-Leclercq, MJ Merino, G Netto, VE Reuter, ...
The American journal of surgical pathology 37 (10), 1518-1531, 2013
2092013
Non‐invasive papillary urothelial neoplasms: the 2004 WHO/ISUP classification system
H Miyamoto, JS Miller, DA Fajardo, TK Lee, GJ Netto, JI Epstein
Pathology international 60 (1), 1-8, 2010
2092010
ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor
Z Yang, YJ Chang, IC Yu, S Yeh, CC Wu, H Miyamoto, DE Merry, ...
Nature medicine 13 (3), 348-353, 2007
2022007
Δ5-Androstenediol is a natural hormone with androgenic activity in human prostate cancer cells
H Miyamoto, S Yeh, H Lardy, E Messing, C Chang
Proceedings of the National Academy of Sciences 95 (19), 11083-11088, 1998
1981998
Telomerase activity in human bladder cancer.
Y Lin, H Miyamoto, K Fujinami, H Uemura, M Hosaka, Y Iwasaki, Y Kubota
Clinical cancer research: an official journal of the American Association …, 1996
1851996
Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells
S Yeh, H Miyamoto, K Nishimura, H Kang, J Ludlow, P Hsiao, C Wang, ...
Biochemical and biophysical research communications 248 (2), 361-367, 1998
1801998
The 2019 Genitourinary Pathology Society (GUPS) white paper on contemporary grading of prostate cancer
JI Epstein, MB Amin, SW Fine, F Algaba, M Aron, DE Baydar, AL Beltran, ...
Archives of pathology & laboratory medicine 145 (4), 461-493, 2021
1752021
Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4–STAT3 signaling
LY Fang, K Izumi, KP Lai, L Liang, L Li, H Miyamoto, WJ Lin, C Chang
Cancer research 73 (18), 5633-5646, 2013
1622013
Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails
AS Duffield, TK Lee, H Miyamoto, HB Carter, JI Epstein
The Journal of urology 182 (5), 2274-2279, 2009
1602009
ASC-J9 suppresses castration-resistant prostate cancer growth through degradation of full-length and splice variant androgen receptors
S Yamashita, KP Lai, KL Chuang, D Xu, H Miyamoto, T Tochigi, ST Pang, ...
Neoplasia 14 (1), 74-IN12, 2012
1572012
ASC-J9 suppresses castration-resistant prostate cancer growth through degradation of full-length and splice variant androgen receptors
S Yamashita, KP Lai, KL Chuang, D Xu, H Miyamoto, T Tochigi, ST Pang, ...
Neoplasia 14 (1), 74-IN12, 2012
1572012
The system can't perform the operation now. Try again later.
Articles 1–20